Protalix BioTherapeutics News - PLX

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Protalix BioTherapeutics Inc PLX AMEX Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.33 9.22% 3.91 3.58 3.95 3.60 3.58 17:03:33
more quote information »

Recent News

Date Time Source Heading
2/18/20205:30IHNWFeatured190% Increase in Revenue -- SinglePoint Announces Preliminary Unaudited 2019 Annual Results, Residential Solar Business Unit is the Primary Driver for the Increase in Revenues and Achieves Business Unit Profitability
2/13/202016:20EDGARAmended Statement of Ownership (sc 13g/a)
2/13/202016:13EDGARAmended Statement of Ownership (sc 13g/a)
2/10/202016:17EDGARCurrent Report Filing (8-k)
2/07/202011:32EDGARAmended Statement of Ownership (sc 13g/a)
2/06/202006:58EDGARCurrent Report Filing (8-k)
2/05/202017:01EDGARStatement of Changes in Beneficial Ownership (4)
1/22/202017:04EDGARStatement of Changes in Beneficial Ownership (4)
1/22/202017:03EDGARStatement of Changes in Beneficial Ownership (4)
1/22/202017:03EDGARStatement of Changes in Beneficial Ownership (4)
1/22/202017:03EDGARStatement of Changes in Beneficial Ownership (4)
1/22/202017:02EDGARStatement of Changes in Beneficial Ownership (4)
1/03/202017:17EDGARInitial Statement of Beneficial Ownership (3)
1/03/202017:16EDGARInitial Statement of Beneficial Ownership (3)
12/20/201906:12EDGARCurrent Report Filing (8-k)
12/19/201907:04EDGARCurrent Report Filing (8-k)
12/17/201915:27EDGARConfidential Treatment Order (ct Order)
12/09/201916:12EDGARCurrent Report Filing (8-k)
11/26/201917:01EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
11/18/201906:57EDGARCurrent Report Filing (8-k)
11/15/201917:02EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
11/12/201916:32EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
11/07/201907:01EDGARQuarterly Report (10-q)
11/07/201906:56EDGARCurrent Report Filing (8-k)
10/17/201908:43EDGARCurrent Report Filing (8-k)
10/15/201916:31EDGARProxy Statement (definitive) (def 14a)
10/04/201916:46EDGARProxy Statement - Notice of Shareholders Meeting..
9/24/201917:01EDGARStatement of Changes in Beneficial Ownership (4)
9/24/201917:00EDGARInitial Statement of Beneficial Ownership (3)
9/24/201907:22EDGARCurrent Report Filing (8-k)
8/30/201916:16EDGARCurrent Report Filing (8-k)
8/30/201916:15GLOBEProtalix BioTherapeutics Receives Listing Deficiency Letter..
8/22/201908:45GLOBEProtalix BioTherapeutics Focuses on Evaluating and Pursuing..
8/13/201916:14EDGARCurrent Report Filing (8-k)
8/13/201916:05GLOBEShlomo Yanai Resigns as Chairman of the Board of Protalix..
8/08/201916:07EDGARQuarterly Report (10-q)
8/08/201906:20EDGARCurrent Report Filing (8-k)
8/08/201906:05GLOBEProtalix BioTherapeutics Reports Second Quarter 2019 Results..
7/29/201916:01GLOBEProtalix BioTherapeutics to Hold Second Quarter 2019..
7/29/201907:09EDGARCurrent Report Filing (8-k)
7/29/201907:00GLOBEProtalix BioTherapeutics Appoints Eyal Rubin as its New..
7/22/201916:05EDGARCurrent Report Filing (8-k)
7/02/201917:57EDGARStatement of Changes in Beneficial Ownership (4)
7/02/201917:56EDGARInitial Statement of Beneficial Ownership (3)
6/17/201907:08EDGARCurrent Report Filing (8-k)
6/17/201907:00GLOBEProtalix BioTherapeutics Completes Enrollment in the Phase..
6/06/201907:11EDGARCurrent Report Filing (8-k)
6/06/201907:00GLOBEProtalix BioTherapeutics and Chiesi Farmaceutici S.p.A to..
5/31/201907:01EDGARCurrent Report Filing (8-k)
5/21/201907:35EDGARCurrent Report Filing (8-k)
5/21/201907:00GLOBEProtalix BioTherapeutics Appoints Dror Bashan as its..
See more news about this stock »


Your Recent History
AMEX
PLX
Protalix B..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.